Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
RE ›
RESVIVAX
Trademark search for:
RESVIVAX
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-04-26 — Application filed
2020-04-29 — Application filed
2020-05-06 — Application filed
2020-07-20 — Final disposition recorded
2020-07-20 — Final disposition recorded
2020-07-20 — Assigned to examiner
2020-07-20 — Final disposition recorded
2021-01-20 — Teas/email correspondence entered
2021-01-20 — Office action issued
2021-01-20 — Correspondence received in law office
2021-02-10 — Office action issued
2021-02-10 — Office action issued
2021-02-10 — Office action issued
2021-04-06 — Teas request for reconsideration received
2021-04-06 — Exparte appeal received at ttab
2021-04-06 — Jurisdiction restored to examining attorney
2021-04-06 — Ex parte appeal-instituted
2021-05-07 — Approved for pub - principal register
2021-05-07 — Teas/email correspondence entered
2021-05-07 — Exparte appeal terminated
2021-05-07 — Correspondence received in law office
2021-05-26 — Notification of notice of publication e-mailed
2021-06-15 — Published for opposition
2021-06-15 — Official gazette publication confirmation e-mailed
2021-08-10 — Noa e-mailed - sou required from applicant
2022-01-18 — Sou teas extension received
2022-01-18 — Sou extension 1 filed
2022-01-18 — Sou extension 1 granted
2022-01-20 — Notice of approval of extension request e-mailed
2022-03-24 — Sou teas extension received
2022-03-24 — Sou extension 2 filed
2022-03-24 — Sou extension 2 granted
2022-03-26 — Notice of approval of extension request e-mailed
2022-12-19 — Sou teas extension received
2022-12-19 — Sou extension 3 filed
2022-12-19 — Sou extension 3 granted
2022-12-21 — Notice of approval of extension request e-mailed
2023-03-29 — Attorney/dom.rep.revoked and/or appointed
2023-03-29 — Teas change of owner address received
2023-03-29 — Teas change of correspondence received
2023-03-29 — Applicant/correspondence changes (non-responsive) entered
2023-03-29 — Teas revoke/app/change addr of atty/dom rep received
2023-04-13 — Sou teas extension received
2023-04-13 — Sou extension 4 granted
2023-04-13 — Sou extension 4 filed
2023-04-15 — Notice of approval of extension request e-mailed
2023-11-27 — Sou teas extension received
2023-11-27 — Sou extension 5 filed
2023-12-07 — Case assigned to intent to use paralegal
2023-12-07 — Sou extension 5 granted
2023-12-08 — Notice of approval of extension request e-mailed
2024-03-04 — Attorney/dom.rep.revoked and/or appointed
2024-03-04 — Teas change of correspondence received
2024-03-04 — Teas revoke/app/change addr of atty/dom rep received
2024-09-16 — Application abandoned
2024-09-16 — Application abandoned
2024-09-16 — Final status recorded
Owner Information
Novavax, Inc.
Gaithersburg , MD
Novavax, Inc.
Gaithersburg , MD
Correspondent
Caroline L. Marsili Carlson, Caspers, Vandenburgh & Lindquist, P.A. 225 S. Sixth Street, Suite 4200 c/o Docketing Department Minneapolis, MN 55402
Filing Details
Filing Date:
2020-04-26
Status Date:
2024-09-16
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.